Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
Bullboard Posts
User Avatar Image
(12)
•••
Comment by YoloRoloon Nov 15, 2018 6:36pm
68 Views
Post# 28983508

RE:Purchases

RE:PurchasesI'm counting 4 machine has been distributed.

The Company has secured two new orders for its VMS+ heart analysis products at leading hospitals in Germany and the United States (more details will follow). 
Read more at https://www.stockhouse.com/news/press-releases/2018/10/17/ventripoint-diagnostics-announces-new-marketing-manager-and-provides-corporate#yMKjb4fHk2BdQzQT.99

(“Ventripoint” or the “Company”, TSXV:VPT, OTCQB:VPTDF) is pleased to announce that the University of Chicago Medical Center in Chicago, Illinois will be receiving the VMS+ complete heart analysis system.
Read more at https://www.stockhouse.com/news/press-releases/2018/11/05/the-university-of-chicago-medical-center-cardiac-department-evaluates-the-vms#mWkWgQEX6PEx5eWw.99      NOT SURE IF THIS ONE WAS A FREE GIVE AWAY SYSTEM.

(“Ventripoint” or the “Company”, TSXV:VPT) is pleased to announce that St. Michael’s Hospital in Toronto,  Canada, has ordered the AI based VMS+ complete heart analysis system for use in clinical evaluations of cardiac patients.
Read more at https://www.stockhouse.com/news/press-releases/2018/11/12/st-michael-s-hospital-a-leading-cardiac-centre-in-canada-orders-the-ventripoint#4qXxcmE0QgCkKWjC.99

Stockhound98 wrote: Does anyone know how many purchases of the VMS+ system that there have now been?

I have lost track, however my suggestion is that this is now more than 5? At USD75,000 a unit?

Thanks


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities